Camp Lejeune cancer lawsuit

Marines Or Survivors Have Two Years From Now To File A Lawsuit

Marines with cancer or survivors of those who have died should speak with an attorney immediately to register their Camp Lejeune water cancer lawsuit

Friday, September 2, 2022 - Thousands of Camp Lejeune water contamination cancer lawsuits are expected to be filed in the weeks and months to come by Marine Corps veterans or their surviving loved ones who drank the local tapwater. The recently enacted into law Camp Lejeune Justice Act nullified the Statute of Repose. Marines with cancer or their survivors now have a two-year window to register a lawsuit seeking lump-sum monetary compensation from the federal government. The lawsuits are expected to be organized into multidistrict litigation (MDL) because of the large number expected to be filed. MDL is preferred to streamline administrative court proceedings to avoid duplication of repetitive court activities. Each case will undergo an individual discovery process. Multi-district litigation will be presided over by one federal judge whose most important job is to select scientific witnesses from a pool presented by each side who will be allowed to testify about the complex science that underlines the plaintiff's accusations, and the government's defense.

The number of plaintiffs that wish to file Camp Lejeune water lawsuits could exceed 100,000. In that case, prospective plaintiffs may be required to pre-register their complaint with a Camp Lejeune water attorney who instructs them to fill out an MDL judge-approved questionnaire and certify the answers are true. Such a questionnaire may include questions that pertain to his/her earlies and subsequent cancer diagnosis, his/her time spent at Camp Lejeune, and similar inquiries. This type of screening will reduce the number of frivolous claims. Multidistrict litigation is not a class action and each case is tried individually and will stand or fall on its own merits. MDL may be organized into two main categories although this is not certain. The first could be Marines and civilian employees that have a type of cancer that is one of those the Veterans Administration (VA) had designated as being caused by their military service. The other grouping could be those with a neurological disease or a type of cancer the VA has not recognized but is suspected to have been caused by repeatedly ingesting the known toxic chemicals. Such suspicions may arise if the marine is otherwise healthy and has no history of the disease in his/her family. It is a fact that the Environmental Protection Agency (EPA) has tested Camp Lejeune water and found it to contain trichloroethylene (TCE), tetrachloroethylene (PCE), vinyl chloride (VC), and benzene. All are odorless and colorless making them difficult to identify until people en-mass get sick. These chemicals are well-known carcinogens and the government may not challenge that they probably caused the plaintiff's cancer or other diseases. There is no guarantee that the plaintiff will achieve a favorable outcome from the court and there is no set payment date if they do. It is likely, however, that if enough Marines come forward with cancer claims, personal damages could be in the billions of dollars and prompt the federal government to offer a settlement rather than take the cases to court.

Information provided by, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.